Bramante
Account
Certificate of Analysis

Recombinant Human FGF2 (bFGF, 154 aa)

GF-FGF2-HU · 1 mg
Lot numberBB-GF-251127-005O
Catalog no.GF-FGF2-HU-1MG
ManufacturedNov 27, 2025
ExpiresNov 17, 2027
AssayMethodAcceptance criterionResultPass
PuritySDS-PAGE & RP-HPLC≥ 98%99.3%PASS
EndotoxinLAL≤ 0.1 EU/µg0.07 EU/µgPASS
Bioactivity (ED50)BALB/c 3T3 fibroblast proliferation0.1–0.6 ng/mL0.4 ng/mLPASS
Molecular weightSDS-PAGE17.2 kDa ± 10%17.1 kDaPASS

Released for sale. All results meet the acceptance criteria published in this product's specification. This Certificate of Analysis applies only to the lot identified above.

Quality Assurance, Bramante Biologics
bramantebio.com/support/coa/BB-GF-251127-005O/